3 ASX Growth Stocks Showing Momentum

Some companies quietly stand out because they are improving operations, expanding steadily and delivering updates that actually matter. Here are three ASX growth stocks that have been making meaningful progress through business performance, pipeline development and clearer growth direction.

Viva Energy Group Limited (ASX: VEA)

Viva Energy Group Limited (ASX: VEA) started FY26 with a stronger base after a much better second half in FY25. The company reported group EBITDA of $700.9 million with second half EBITDA rising to $396 million as operations improved and market conditions became more supportive. 

Its Commercial & Industrial segment delivered record sales volumes which shows the strength of its core business even in a mixed environment. On the retail side the full acquisition of Liberty Convenience, 35 new OTR stores and better execution helped earnings recover in the later part of the year. 

Viva Energy also commissioned its Ultra Low Sulphur Gasoline plant ahead of fuel specification changes which should support refining quality and margins going forward. 

In the wider space of ASX growth stocks Viva Energy looks more like a steady builder than a flashy story with infrastructure strength, improving retail performance and a clearer growth agenda for FY26.

Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Limited (ASX: TLX) is making steady progress in its cancer imaging and treatment pipeline.

In March 2026, the company resubmitted its NDA to the U.S. FDA for TLX101-Px, a brain cancer imaging candidate. This product is designed to help doctors better identify whether a patient’s glioma has returned, worsened or if the changes are only due to earlier treatment. This matters because, according to Telix there is currently no FDA approved targeted amino acid PET imaging agent commercially available in the U.S. for this purpose.

The company also announced encouraging data from Part 1 of its global Phase 3 ProstACT study where TLX591-Tx achieved its primary objectives with an acceptable safety and tolerability profile. 

What stands out here is that Telix is advancing more than one important program at the same time. Among ASX growth stocks this gives the company a deeper pipeline story rather than dependence on a single product update.

Technology One Limited (ASX: TNE)

Technology One Limited (ASX: TNE) is showing that consistent software growth can still be powerful when backed by strong execution. 

At its 2025 AGM the company highlighted 19% profit growth to $181.5 million and ARR growth of 18% to $554.6 million. It also reported a Rule of 40 result of 59% which reflects a solid balance between growth and cash generation. 

The company then upgraded its FY26 guidance. It is now expecting profit growth of 18% to 20% and ARR growth of 16% to 18%. Management linked this confidence to momentum in SaaS+, a strong customer pipeline across Australia, New Zealand and the UK and new AI led product launches. 

That mix gives the story both stability and future upside. In the broader group of ASX growth stocks Technology One feels like the kind of business that compounds quietly with recurring revenue, disciplined execution, and confidence backed by operating performance rather than hype. 

(Source: Company Reports)